These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3125517)

  • 1. Resistance to quinolones.
    Mouton RP
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S11-5. PubMed ID: 3125517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates.
    Rubinstein E; Mark Z; Samra Y; Alkan M; Berger S
    Chemioterapia; 1986 Apr; 5(2):75-82. PubMed ID: 2939966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial resistance to fluoroquinolones.
    Neu HC
    Rev Infect Dis; 1988; 10 Suppl 1():S57-63. PubMed ID: 3279500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Statistical observation on chronological changes of sensitivity of various bacteria to antibiotics. 1. Gram negative bacilli; Escherichia coli, Bacillus pneumoniae, Proteus vulgaris, Alcaligenes faecalis, Cloaca, Providencia, Citrobactor, Pseudomonas aeruginosa (1966-71)].
    Fukazawa S; Ogi Kayoko Shimoama Y; Shimogaki F; Uete T
    Nihon Rinsho; 1973 Feb; 31(2):457-65. PubMed ID: 4198261
    [No Abstract]   [Full Text] [Related]  

  • 5. The frequency of in-vitro resistance development to fluoroquinolones and the use of a murine pyelonephritis model to demonstrate selection of resistance in vivo.
    Fernandes PB; Hanson CW; Stamm JM; Vojtko C; Shipkowitz NL; St Martin E
    J Antimicrob Chemother; 1987 Apr; 19(4):449-65. PubMed ID: 3108227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amifloxacin activity against well-defined gentamicin-resistant, gram-negative bacteria.
    John JF; Twitty JA
    Antimicrob Agents Chemother; 1984 Nov; 26(5):781-4. PubMed ID: 6440481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms and frequency of resistance to temafloxacin.
    Appelbaum PC
    Am J Med; 1991 Dec; 91(6A):27S-30S. PubMed ID: 1662892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mode of action of 4-quinolones and possible mechanisms of resistance.
    Smith JT
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():21-9. PubMed ID: 3542946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT
    Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy studies of ciprofloxacin and other quinolone derivatives in combination with further antibiotics.
    Höffler U
    Chemioterapia; 1987 Jun; 6(2 Suppl):140-2. PubMed ID: 2855612
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1987). III. Secular changes in susceptibility].
    Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1990 Jun; 43(6):968-1136. PubMed ID: 2122041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9/sgRNA-mediated targeted gene modification confirms the cause-effect relationship between gyrA mutation and quinolone resistance in Escherichia coli.
    Qiu H; Gong J; Butaye P; Lu G; Huang K; Zhu G; Zhang J; Hathcock T; Cheng D; Wang C
    FEMS Microbiol Lett; 2018 Jul; 365(13):. PubMed ID: 29767711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antibacterial activity of some substituted 4-quinolone-3-carboxylic acids.
    Markees DG; Schwab LS; Vegotsky A
    J Med Chem; 1974 Jan; 17(1):137-9. PubMed ID: 4202214
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimicrobial activity os some 7-nitro-and 7-amino-dialkylaminomethyl-8-hydroxyquinolines.
    Nardi D; Massarani E; Tajana A; Degen L
    Arzneimittelforschung; 1973 Feb; 23(2):285-6. PubMed ID: 4633839
    [No Abstract]   [Full Text] [Related]  

  • 15. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A; Phillips I
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy of fluoroquinolones with other antimicrobial agents.
    Neu HC
    Rev Infect Dis; 1989; 11 Suppl 5():S1025-35. PubMed ID: 2505355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of amifloxacin (WIN 49, 375), a new quinolone agent.
    Neu HC; Labthavikul P
    Diagn Microbiol Infect Dis; 1985 Nov; 3(6):469-78. PubMed ID: 4064609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
    Bassey CM; Baltch AL; Smith RP
    J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of quinolone resistance in clinical isolates: accumulation of sparfloxacin and of fluoroquinolones of various hydrophobicity, and analysis of membrane composition.
    Denis A; Moreau NJ
    J Antimicrob Chemother; 1993 Sep; 32(3):379-92. PubMed ID: 8262860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antimicrobial activities of major oral antibacterial agents against clinically isolated microbial strains from inpatients].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y
    Jpn J Antibiot; 1992 Aug; 45(8):965-79. PubMed ID: 1433903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.